Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Energy and Renewables
  • IT & Communications
  • Chemicals & Materials
  • Biotech
  • Healthcare

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • Top 10 Holdings
    by value
Chemicals & Materials

University: Southampton

Company Stage: Quoted

Website: http://www.ilika.com

Ilika

Ilika Technologies is focused on high throughput methods of screening, synthesising and characterising very large numbers of new materials.

High throughput combinatorial chemistry has already had a significant impact on the pharmaceutical industry where the technique is widely used within the drug discovery process to synthesise and screen large numbers of new compounds. Ilika has been formed to introduce similar techniques to other chemical and materials industries, with the objective of dramatically accelerating the discovery of new materials with commercial value.

As at 31 Dec 2012

IP Group holding

IP Venture Fund* holding

8.8%

7.6%
 

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Ilika

Related news

20 Feb 2014
11 Feb 2014

There is currently no news available.

More portfolio news